Study to Evaluate Enfortumab Vedotin in Subjects with Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)(7465-CL-202)
Study to Evaluate Enfortumab Vedotin in Subjects with Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)(7465-CL-202)
Trial Category:
Gastrointestinal
Phase
II
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE